CDC:

• Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis




• Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 MMWR 54(RR15);1-37

• Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005 MMWR Vol. 54 / RR17;1-141.

• MMWR: Errata: Treatment of Tuberculosis MMWR 2005; 52, (RR-11)

• Guidelines for Using the QuantiFERON^®-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States MMWR Recommendations and Reports, December 16, 2005 / Vol. 54 / No. RR-15

• TB/HIV Drug Interactions, 2004, Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors

• Treatment of Tuberculosis American Thoracic Society, CDC, and Infectious Diseases Society of America MMWR Recommendations and Reports 2003: 52, (RR11);1-77

• Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection---United States, 2003 MMWR 2003; 52 (No. 31)

• Public Health Dispatch: Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide Treatment for Latent Tuberculosis Infection MMWR Weekly 2002, Vol. 51 / No. 44, pages 998 - 999

• Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations --- United States, 2001 MMWR Weekly, Vol. 50 / No. 34, pages 733-735

• Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection  MMWR Recommendations and Reports 2000, Vol. 49 / No. RR-06

• Diagnostic Standards and Classification of Tuberculosis in Adults and Children , Am J Respir Crit Care Med Vol 161. pp 1376–1395, 2000

• Notice to Reader: Update: Nucleic Acid Amplication Test for Tuberculosis , MMWR 2000, Vol 49, pages 593-594

• Notice to Readers: Acquired Rifamycin Resistance in Persons with Advanced HIV Disease Being Treated for Active Tuberculosis with Intermittent Rifamycin-Based Regimens MMWR Weekly, Vol. 51 / No. 10, pages 214-215

• Prevention and Treatment of Tuberculosis Among Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations MMWR Recommendations and Reports, Vol. 47 / No. RR-20

• Public Health Service Guidelines for the Management of Health-Care Worker Exposures to HIV and Recommendations for Postexposure Prophylaxis MMWR Recommendations and Reports, Vol. 47 / RR-07

• Anergy Skin Testing and Preventive Therapy for HIV-Infected Persons: Revised Recommendations MMWR Recommendations and Reports, Vol. 46 / No. RR-15 1-10

• Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Aniretroviral Agents in HIV-Infected Adults and Adolescents HIV/AIDS Treatment Information Service (ATIS) report, 121 pages

• Clinical Update: Impact of HIV Protease Inhibitors on the Treatment of HIV-Infected Tuberculosis Patients with Rifampin MMWR Weekly, Vol. 45 / No. 42, pages 921-925

• Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis, Recommendations from the National Tuberculosis Controllers Association and CDC MMWR Recommendations and Reports, Vol. 54(RR15);1-37

• Exposure of Passengers and Flight Crew to Mycobacterium tuberculosis on Commercial Aircraft, 1992-1995 MMWR Weekly, Vol. 44 / No. 8, pages 137-140